PDCD1 and neoplasm: Mice were treated as in Figure 5A. Combined administration of ACA + anti-PD-1 yielded significantly reduced tumor weights relative to CON no therapy (NT) mice on day 21, whereas anti-PD-1 had a minimal effect on tumor burdens in mice on CON diet (Figure 5B).